Major gaps in XXXX clinical care among Canada's First Nations: results of the CIRCLE study.

@entity1 @entity101 @entity3916 @entity6 @entity2299 @entity28 @entity66 @entity740 @entity453
AIMS: The aim of this cross-sectional study was to document the clinical management of type 2 @entity6 and related complications in Canada's First Nations. METHODS: @entity1 were randomly selected from 19 communities. Data from charts from consenting @entity1 were collected. RESULTS: Of 885 @entity1 , 63.3% were female, mean age was 54.9 years and mean duration of T2DM was 11.2 years. Mean @entity3916 was 8.2%; 61.1% of @entity1 had an @entity3916 >7.0%; mean LDL was 2.4 mmol/L; 92.6% had @entity2299 ; mean systolic BP was 132 mm Hg; mean diastolic BP was 76 mm Hg; 92.0% had @entity101 . Lipid-lowering medications were prescribed to 62.9% of those with @entity2299 and an LDL-C >2.0 mmol/L. Of @entity101 @entity1 , 15.8% were not on an antihypertensive agent. For vascular protection, 55.1% were on a statin, 72.1% on an ACE inhibitor or ARB, and 64.5% on an anticoagulant. Smoking was documented in 39.4%, 92.1% were overweight/ @entity28 ; 55.1% had @entity740 , and 13.3% had @entity453 . CONCLUSIONS: Major care gaps were revealed, with most @entity1 not achieving glycemic, lipid and BP targets. Over half of this relatively young cohort had established microvascular disease. @entity66 rates may increase dramatically due to the high prevalence of risk factors.
